Recently, we have reported that reduced IRF4 expression distinguishes trisomy 12 CLL from other CLL cases, implying a possible involvement of IRF4 in the peculiar properties of this subset (13). This evidence concerns the gene IRF4 and B-cell chronic lymphocytic leukemia.